Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Apr;32(1):243–250. doi: 10.1128/iai.32.1.243-250.1981

Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

J J Munoz, H Arai, R L Cole
PMCID: PMC350613  PMID: 6260681

Abstract

We compared the protective activities of fimbrial hemagglutinin (FHA) and pertussigen and their respective antibodies in mice infected intracerebrally with Bordetella pertussis. We found that mice were protected by a 1.7-microgram/mouse dose of pertussigen which was free of detectable FHA and was detoxified by treatment with glutaraldehyde. A pertussigen preparation made from cells grown in shake cultures that did not contain demonstrable FHA protected mice at a dose of 1.4 microgram/mouse. FHA at a dose of 10 microgram/mouse protected mice from intracerebral infection, but it also sensitized mice to histamine at a dose of 2 micrograms/mouse, which indicated that it was contaminated with pertussigen. When FHA was obtained free of demonstrable pertussigen, it failed to sensitize mice to histamine at a dose of 30 micrograms/mouse and to protect mice from infection at a dose of 12 micrograms/mouse (largest doses tested). Passive protection tests with antisera known to contain antibodies to pertussigen protected mice from intracerebral infection, whereas sera lacking anti-pertussigen antibodies but containing high concentrations of anti-FHA antibodies did not protect mice. The most important antigen for the immunization of mice against intracerebral infection with B. pertussis appears to be pertussigen.

Full text

PDF
243

Images in this article

247Image
on p.247
248Image
on p.248
248Image
on p.248
249Image
on p.249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Munoz J. J. Crystallization of pertussigen from Bordetella pertussis. Infect Immun. 1981 Jan;31(1):495–499. doi: 10.1128/iai.31.1.495-499.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arai H., Munoz J. J. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis. Infect Immun. 1979 Aug;25(2):764–767. doi: 10.1128/iai.25.2.764-767.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arai H., Munoz J. J. Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis. Infect Immun. 1979 Jul;25(1):460–462. doi: 10.1128/iai.25.1.460-462.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arai H., Sato Y. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochim Biophys Acta. 1976 Oct 22;444(3):765–782. doi: 10.1016/0304-4165(76)90323-8. [DOI] [PubMed] [Google Scholar]
  5. DOLBY J. M. The separation of the histamine-sensitizing factor from the protective antigens of Bordetella pertussis. Immunology. 1958 Oct;1(4):328–337. [PMC free article] [PubMed] [Google Scholar]
  6. ELDERING G., HORNBECK C., BAKER J. Serological study of Bordetella pertussis and related species. J Bacteriol. 1957 Aug;74(2):133–136. doi: 10.1128/jb.74.2.133-136.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kurokawa M., Iwasa S., Ishida S. On a possible new kind of toxic substance produced by Bordetella pertussis. Jpn J Med Sci Biol. 1965 Jun;18(3):161–165. doi: 10.7883/yoken1952.18.161. [DOI] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. MASRY F. L. G. Production, extraction and purification of haemagglutinin of Haemophilus pertussis. J Gen Microbiol. 1952 Nov;7(3-4):201–210. doi: 10.1099/00221287-7-3-4-201. [DOI] [PubMed] [Google Scholar]
  10. MUNOZ J., HESTEKIN B. M. Antigens of Bordetella pertussis. III. The protective antigen. Proc Soc Exp Biol Med. 1963 Mar;112:799–805. doi: 10.3181/00379727-112-28173. [DOI] [PubMed] [Google Scholar]
  11. Morse S. I. Biologically active components and properties of Bordetella pertussis. Adv Appl Microbiol. 1976;20:9–26. doi: 10.1016/s0065-2164(08)70106-0. [DOI] [PubMed] [Google Scholar]
  12. NIWA M. Histamine sensitizing factor of Bordetella pertussis. J Biochem. 1962 Mar;51:222–230. doi: 10.1093/oxfordjournals.jbchem.a127524. [DOI] [PubMed] [Google Scholar]
  13. PILLEMER L. Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata. Proc Soc Exp Biol Med. 1950 Dec;75(3):704–705. doi: 10.3181/00379727-75-18311. [DOI] [PubMed] [Google Scholar]
  14. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis. 1979 May-Jun;1(3):401–412. doi: 10.1093/clinids/1.3.401. [DOI] [PubMed] [Google Scholar]
  15. Preston N. W., Stanbridge T. N. Mouse or man? Which are pertussis vaccines to protect? J Hyg (Lond) 1976 Apr;76(2):249–256. doi: 10.1017/s0022172400055145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ross R., Munoz J., Cameron C. Histamine-sensitizing factor, mouse-protective antigens, and other antigens of some members of the genus Bordetella. J Bacteriol. 1969 Jul;99(1):57–64. doi: 10.1128/jb.99.1.57-64.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sato Y., Arai H. Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization. Infect Immun. 1972 Dec;6(6):899–904. doi: 10.1128/iai.6.6.899-904.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sato Y., Arai H., Suzuki K. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun. 1974 May;9(5):801–810. doi: 10.1128/iai.9.5.801-810.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sato Y., Arai H., Suzuki K. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties. Infect Immun. 1973 Jun;7(6):992–999. doi: 10.1128/iai.7.6.992-999.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stainer D. W., Scholte M. J. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 1970 Oct;63(2):211–220. doi: 10.1099/00221287-63-2-211. [DOI] [PubMed] [Google Scholar]
  21. THIELE E. H. Studies on the hemagglutinin of Hemophilus pertussis. J Immunol. 1950 Dec;65(6):627–632. [PubMed] [Google Scholar]
  22. Yajima M., Hosoda K., Kanbayashi Y., Nakamura T., Nogimori K., Mizushima Y., Nakase Y., Ui M. Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem. 1978 Jan;83(1):295–303. doi: 10.1093/oxfordjournals.jbchem.a131904. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES